01:43

Enterin ENT-01 MoA animation

01:05

N1 Life METATIDE MoA animation

01:37

Unity Biotechnology UBX1325 MoA on DME @Visual Science

00:54

Unity Biotechnology UBX1325 MoA on AMD @Visual Science

00:15

Revolution Medicines: High-end 3D animation. Tri-complex 3D assembly

00:40

MediWound Core Platform MoA Animation

01:49

LineaRx enzymatic platform for large-scale DNA manufacturing

01:02

Revolution Medicines KRAS pathway animation

01:01

Atsena Therapeutics: Spreading vector animation

01:01

Revolution Medicines RAS(ON) inhibitors MoA animation

01:13

High-end 3D animation on LINE-1 reverse transcriptase

02:19

Visual Science MoA animation Reel 2023

00:38

CASE STUDY. MoA animations about virus-based immunotherapy platforms for Candel Therapeutics (NA...

00:52

CASE STUDY. Metatide peptide 3D Mechanism of Action animation for N1 Life

00:54

CASE STUDY. Media kit for Revolution Medicines (NAS: RVMD)

00:33

CASE STUDY. UBX1325 MoA in Diabetic Macular Edema for Unity Biotechnology (NAS: UBX)

00:30

CASE STUDY. UBX1325 MoA in Age-related Macular Degeneration for Unity Biotechnology (NAS: UBX)

00:47

CASE STUDY. High-end Mechanism of Action animation on CRISPR gene-editing systems

00:34

CASE STUDY. Mechanism of Action animation about Redpin Tx's (acquired by Kriya Therapeutics) che...

00:47

CASE STUDY. Mechanism of Action animation for Enterin

00:52

Tissue Repair Core Platform Technology Mechanism of Action animation for MediWound Ltd. (NAS: MDWD)

00:41

Explainer Animation: Large-scale DNA Manufacturing Platform for Applied DNA Sciences (NAS: APDN)

00:51

LINE-1 Reverse Transcriptase Case Study for ROME Therapeutics

02:26

Visual Science MoA/MoD animations. Demoreel 2023

00:38

CASE STUDY. Mechanism of Technology and Device Animations. Apton Biosystems

00:40

CASE STUDY. UNI-494 drug Mechanism of Action for Unicycive Therapeutics (NAS: UNCY)

02:28

Scientific animation for drug-hunting platform. Scorpion Therapeutics

01:13

3D animation-presentation type

01:39

MoA animation for Redpin Therapeutics' IR and corporate communication.

01:06

Atsena Therapeutics: Dual Vector animation. MoA animation

01:01

MoA animation for Atsena Therapeutics' investor deck and website

02:07

Neoleukin NL-201 MoA animation. De novo protein development platform

02:10

Quantitative Amplicon Sequencing (QASeq) NUPROBE 3D animation by Visual-Science

01:05

pH-Low Insertion Peptide Platform Technology for targeted delivery

00:08

High-end real-time AR application: Zika virus AR mode

00:08

High-end real- time AR application: Rhinovirus AR model

00:08

High-end real-time AR application: Immunoglobulin G

00:18

Visual Cortex Activation. 3D animation for holographic projection

01:41

3D model of the SARS-CoV-2 virus at atomic resolution

00:48

Identification of target DNA sequences by Lac repressor and CRISPR-Cas9 complex

03:05

Anti-hypoxia Therapy — Mechanism of Action (MOA)

00:33

Cybrexa Therapeutics Tumor Specific Drugs Mechanism of Action (MOA)

00:57

Visual Science Short Medical Reel — Early 2017

00:29

Curaxin MOA Animation for Roswell Park Cancer Institute

00:23

HIV Scientifically Accurate 3D Model

00:22

Influenza A/H1N1 (Swine Flu) — Scientifically Accurate 3D Model

00:19

Human Papillomavirus (HPV) — Scientifically Accurate 3D Model

00:30

Zika Virus - Scientifically Accurate 3D Model

00:10

Ebola Virus 3D Animation Short

00:08

Botulotoxin A animation short

00:15

Immunoglobulin G (IgG) animation for Monash University and Wiley

00:16

Hemoglobin deoxy — oxy animation for Monash University and Wiley

00:22

LeFort I, II and III type fractures — animation shorts for Monash University, Australia

03:20

How do CRISPR gene-editing systems work?

03:14

What is a quantum computer? An animation for Nature Outline

02:28

Zika Virus 3D VR. Virtual Reality Animation